Physician profile

Lawrence Rice

Ophthalmology · La Mesa, CA

NPI 1922060805

$1,147.77

in general payments reported to CMS, 2019-2025

16 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Sight Sciences, INC. $332.97 2019-2022
Novartis Pharmaceuticals Corporation $152.48 2019-2022
Aerie Pharmaceuticals, INC. $125.36 2019
Allergan, INC. $95.47 2020-2021
Janssen Pharmaceuticals, INC $77.15 2021-2022
Horizon Therapeutics Plc $67.13 2021-2022
Alcon Vision LLC $45.96 2019-2021
Sun Pharmaceutical Industries INC. $44.01 2020-2021
Bausch & Lomb, A Division of Bausch Health US, LLC $43.71 2021
Oyster Point Pharma, INC. $35.97 2022
Dompe US, INC. $34.44 2022
Rxsight INC $21.13 2022
Celgene Corporation $20.48 2022
Kala Pharmaceuticals, INC. $17.78 2020
Abbvie INC. $17.53 2022
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Biohaven Pharmaceutical Holding Company Ltd. $16.20 2022

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Lawrence Rice

$1,147.77

in general payments reported 2019-2025

Years
2019-2022
Top company
Sight Sciences, INC.

https://glasscript.com/doctor/269039/lawrence-rice

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.